Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy

ObjectiveGallbladder cancer (GBC) is highly malignant and is often diagnosed at the advanced stage. Lack of opportunity to surgery results in an unsatisfactory outcome. This pilot study employed gemcitabine combined with nab-paclitaxel (AG) as a conversion therapeutic measure for locally advanced GB...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ziyi Yang, Ziyou Wu, Yichen Xiong, Shilei Liu, Chen Cai, Ziyu Shao, Yidi Zhu, Xiaoling Song, Wei Shen, Xuefeng Wang, Xiangsong Wu, Wei Gong
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-08-01
coleção:	Frontiers in Oncology
Assuntos:	gallbladder cancer resectability gemcitabine nab-paclitaxel conversion therapy
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.977963/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!